American Society of Clinical Oncology

SHERPA: White

People

  1. Iasonos
    Iasonos
  2. Aghajanian
    Aghajanian
  3. Bajorin
    Bajorin
  4. Grisham
    Grisham
  5. Konner
    Konner
  6. Ostrovnaya
    Ostrovnaya
  7. Regazzi
    Regazzi
  8. Hensley
    Hensley
  9. Ma
    Ma
  10. Sabbatini
    Sabbatini

Groups

  1. Biostatistics Service (5)
  2. Department of Medicine (5)
  3. Epidemiology and Biostatistics (5)
  4. Solid Tumor Oncology Division (5)
  5. GDMT, Medicine (3)
  6. Gynecologic Medicine Service (3)
  7. Gynecology Disease Management Team (3)
  8. Nursing (3)
  9. Early Drug Development Service (2)
  10. Genitourinary Oncology Service (2)
Search Within
  1. "2011"
  2. "Epidemiology and Biostatistics"
  3. "Alexia Iasonos"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (1)
Groups
  1. Biostatistics Service (5)
  2. Department of Medicine (5)
  3. Epidemiology and Biostatistics (5)
  4. Solid Tumor Oncology Division (5)
  5. GDMT, Medicine (3)
  6. Gynecologic Medicine Service (3)

More Groups

People
  1. Alexia Iasonos (5)
  2. Carol Aghajanian (3)
  3. Alisa Trout (2)
  4. Arjun Balar (2)
  5. Ashley Regazzi (2)
  6. David Gallagher (2)

More People

Years
  1. 2011 (5)
Publications
  1. Journal of Clinical Oncology (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Topoisomerase I inhibition in BRCA+ and BRCA- ovarian cancer (OC): A single-institution experience
    Meeting Abstract

    Hyman, D. M.; Zhou, Q.; Arnold, A. G.; Grisham, R. N.; Bhatia, J.; Aghajanian, C.; Iasonos, A.; Spriggs, D. R.; Kauff, N. D.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Gemcitabine for advanced endometrial carcinoma (EMC): A review of the MSKCC experience
    Meeting Abstract

    Grisham, R. N.; Adaniel, C. H.; Hyman, D. M.; Ma, W.; Iasonos, A.; Aghajanian, C.; Konner, J. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II trial of gemcitabine, carboplatin, and bevacizumab (Bev) in patients (pts) with advanced/metastatic urothelial carcinoma (UC)
    Meeting Abstract

    Balar, A. V.; Milowsky, M. I.; Apolo, A. B.; Ostrovnaya, I.; Iasonos, A.; Trout, A.; Regazzi, A. M.; Garcia-Grossman, I. R.; Gallagher, D. J.; Bajorin, D. F.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II trial of gemcitabine, carboplatin, and bevacizumab in chemotherapy-naive patients (Pts) with advanced/metastatic urothelial carcinoma (UC)
    Meeting Abstract

    Balar, A. V.; Milowsky, M. I.; Apolo, A. B.; Ostrovnaya, I.; Iasonos, A.; Trout, A.; Regazzi, A. M.; Garcia-Grossman, I. R.; Gallagher, D. J.; Bajorin, D. F.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of intraperitoneal paclitaxel plus cisplatin and intravenous paclitaxel plus bevacizumab as adjuvant treatment of optimal stage II/III epithelial ovarian cancer
    Journal Article

    Konner, J. A.; Grabon, D. M.; Gerst, S. R.; Iasonos, A.; Thaler, H.; Pezzulli, S. D.; Sabbatini, P. J.; Bell-Mcguinn, K. M.; Tew, W. P.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save